The year has come to and end, and I am sure you would all agree that this has been a tumultuous year. We had a financial crisis that is said to be the worst since the great depression, and a crisis of this magnitude doesn’t go by the biotech industry without leaving any trace. Raising [...]

Read the rest of this entry »